European regulators have backed RET inhibitor and PD-1 regimens, expanding first line options in advanced lung, thyroid, and esophageal cancers.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/ema-clears-new-first-line-options-advanced-cancers-2026a10009sa?src=rss
Author :
Publish date : 2026-03-31 12:36:00
Copyright for syndicated content belongs to the linked Source.
